Researcher
Dirk Hose
- Keywords:Medicine
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Mar 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Mar 2020 → 20 Oct 2022
Publications
21 - 30 of 109
- Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma(2021)
Authors: Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thomas Hielscher, Marc-Steffen Raab, Jens Hillengass, Sandra Sauer, Carsten Müller-Tidow, et al.
Pages: 1134-1144 - Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age(2021)
Authors: Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Markus Munder, Hans-Walter Lindemann, Maximilian Merz, et al.
Pages: 809-822 - Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma(2021)
Authors: Marc-Andrea Baertsch, Elias K Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, et al.
- CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma(2021)
Authors: Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaerts, Philip Vlummens, Serge Muyldermans, et al.
- Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease(2020)
Authors: Mike J. Mason, Carolina Schinke, Christine L P Eng, Fadi Towfic, Fred Gruber, Andrew Dervan, Brian S White, Aditya Pratapa, Yuanfang Guan, Hongjie Chen, et al.
Pages: 1866-1874 - Copresentation of BMP-6 and RGD Ligands Enhances Cell Adhesion and BMP-Mediated Signaling(2019)
Authors: Francesca Posa, Anna Luise Grab, Volker Martin, Dirk Hose, Anja Seckinger, Giorgio Mori, Slobodan Vukicevic, Elisabetta Ada Cavalcanti-Adam
- Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells(2019)
Authors: Fabrice F Darche, Rasmus Rivinius, Eva Köllensperger, Uwe Leimer, Günter Germann, Anja Seckinger, Dirk Hose, Julian Schröter, Claus Bruehl, Andreas Draguhn, et al.
- Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma(2019)
Authors: Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sauer, Steffen Luntz, Uta Bertsch, Marc S Raab, et al.
- Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial(2019)
Authors: Dirk Hose, Susanne Beck, Hans J Salwender, Martina Emde-Rajaratnam, Uta Bertsch, Christina Kunz, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, et al.
- Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients(2019)
Authors: Katharina Kriegsmann, Marc-Andrea Baertsch, Mohamed H S Awwad, Maximilian Merz, Dirk Hose, Anja Seckinger, Anna Jauch, Natalia Becker, Axel Benner, Marc S Raab, et al.